ELITE PHARMACEUTICALS INC /NV/ 4/A
4/A · ELITE PHARMACEUTICALS INC /NV/ · Filed May 13, 2015
Insider Transaction Report
Form 4/AAmended
NIGALAYE ASHOK G
DirectorChief Scientific Officer10% Owner
Transactions
- Conversion
Warrants
2015-01-06$0.06/sh−1,500,000$93,750→ 2,924,333 totalExercise: $0.06From: 2009-10-30Exp: 2016-10-30→ Common Stock (1,500,000 underlying)
Footnotes (1)
- [F1]In the original filing, the warrants converted were deducted from the incorrect warrant resulting in an incorrect warrant balance. The issue date, expiration date and exercise price are the same on the original filing and this amended filing.